As reported by the BBC,women will have access to two-step abortive pills.
The initiative was originally devised to help the NHS cope with the overload of patients resulting from COVID.
It has now been announced that women that have not crossed the 10 week pregnancy limit will have access to the set of abortive pills after prescription.
The new law sets forth that the prescribing doctors must leave a written record of the place of abortion as well as details of the consultation before prescribing the pills.
The surgery and anaesthetic-free process involves the initial intake of mifepristone. The latter inhibits the hormone allowing the ongoing pregnancy. The second intake 24 to 48 hours later involves misoprostol, which causes the contraction of the womb to pass the pregnancy. After approximately six hours, bleeding occurs and loss of pregnancy is initiated.
In its endeavour to bettering care for women, the government has furthermore announced that independent clinics and hospitals have been approved to provide the new permanent service.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment